Ospen 1000 (Phenoxymethylpenicillin Potassium)

Phenoxymethylpenicillin potassium is used for infections caused by susceptible Gram‑positive bacteria, particularly in the upper respiratory tract and skin.

• Acute otitis media: helps eradicate the causative bacteria and relieve ear pain.
• Streptococcal pharyngitis: shortens symptom duration and prevents complications.
• Skin and soft‑tissue infections: reduces bacterial load and promotes healing.
• Rheumatic fever prophylaxis: prevents recurrence of streptococcal infection.
• Community‑acquired pneumonia: contributes to bacterial clearance in mild cases.

• Phenoxymethylpenicillin potassium exerts its antibacterial effect by binding to penicillin‑binding proteins on the bacterial cell wall. This inhibits the transpeptidation step of peptidoglycan synthesis, weakening the wall and leading to osmotic lysis of susceptible Gram‑positive organisms.

Phenoxymethylpenicillin potassium is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Nausea or upset stomach.
• Diarrhea, which may be mild and self‑limiting.
• Skin rash or mild itching.
• Vaginal candidiasis in women.
• Transient elevation of liver enzymes.

Serious or Rare Side Effects

• Anaphylactic or severe allergic reactions.
• Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Hemolytic anemia.
• Severe neutropenia or agranulocytosis.
• Clostridioides difficile‑associated colitis.
• Serum sickness‑like reactions.

Phenoxymethylpenicillin potassium should be used with caution in specific clinical situations.

• Allergy assessment: avoid if the patient has a known penicillin hypersensitivity.
• Renal function: dose adjustment may be required in severe impairment.
• Hepatic disease: monitor liver function during prolonged therapy.
• Concomitant oral contraceptives: efficacy may be reduced; advise additional contraception.
• Pregnancy and lactation: use only if clearly needed, after risk‑benefit evaluation.
• Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Phenoxymethylpenicillin potassium can interact with several medicines, requiring clinical awareness.

Major Interactions (Avoid)

• Methotrexate: increased toxicity due to reduced renal clearance.
• Oral anticoagulants (e.g., warfarin): enhanced anticoagulant effect, monitor INR.

Moderate Interactions (Monitor Closely)

• Oral contraceptives: possible reduction in efficacy, consider backup method.
• Allopurinol: may increase risk of rash.
• Probenecid: raises penicillin plasma levels, may require dose adjustment.
• Tetracyclines: antagonistic effect on bacterial killing.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase risk of kidney injury when combined with high‑dose penicillins.